Biotechnology Assets converts EUR 200,000 bonds into 1,052,630 shares at EUR 0.19 each

Reuters2026/08/31 16:53

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Biotechnology Assets converted 20 obligaciones convertibles worth EUR 200,000 into equity at EUR 0.19 per share.
Capital increase executed on Aug. 25, 2026 through issuance of 1,052,630 new shares with EUR 0.14 share premium.
Paid-in proceeds totaled EUR 199,999.70, including EUR 147,368.20 in share premium.
Share capital now stands at EUR 3,806,376.10, divided into 76,127,522 shares.
Listing of the new shares on BME Growth expected once registered with Iberclear.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biotechnology Assets SA published the original content used to generate this news brief on August 31, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Biotechnology Assets converts EUR 200,000 bonds into 1,052,630 shares at EUR 0.19 each

You may also like

Crypto prices